Fig. 7: GATA6 and MUC1 are significantly associated with poor prognosis in CCA patients.

a–f Expression of GATA6 and MUC1 impacts overall survival and tumour recurrence in 91 patients with CCA following surgical resection by Kaplan–Meier analysis. g Cox analysis for overall survival and recurrence-free survival of 91 patients with CCA following surgical resection. GATA6p: GATA6 positive. GATA6N: GATA6 negative. MUC1H: MUC1 high expression. MUC1L: MUC1 low expression. *Statistical significance.